Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clin Mol Hepatol. 2023;29(4):851-868. Published online 2023 Mar 9 DOI: https://doi.org/10.3350/cmh.2022.0434
|
Citations to this article as recorded by
An RNA‐degrading enzyme emerges as a biomarker in a study of human hepatitis virus B
Takehisa Watanabe, Katsuya Nagaoka
Hepatology Research.2024; 54(3): 220. CrossRef Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy
Ritsuzo Kozuka, Masaru Enomoto, Yoshimi Yukawa‐Muto, Naoshi Odagiri, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida‐Kobayashi, Norifumi Kawada
Hepatology Research.2024; 54(7): 615. CrossRef Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
Tomohiro Nishikawa, Masahiro Matsui, Saori Onishi, Kosuke Ushiro, Akira Asai, Soo-Ki Kim, Hiroki Nishikawa
International Journal of Molecular Sciences.2024; 25(4): 2245. CrossRef Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment
Lisa Sandmann, Birgit Bremer, Valerie Ohlendorf, Jerzy Jaroszewicz, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
Viruses.2024; 16(2): 255. CrossRef Identification of dihydroquinolizinone derivatives with nitrogen heterocycle moieties as new anti-HBV agents
Huijuan Song, Shangze Yang, Shuo Wu, Xiaoyu Qin, Ya Wang, Xican Ma, Jiaqi Gong, Meng Wei, Apeng Wang, Mengyuan Wang, Kun Lan, Juan Guo, Mingliang Liu, Xingjuan Chen, Yuhuan Li, Kai Lv
European Journal of Medicinal Chemistry.2024; 268: 116280. CrossRef Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B
Yong-Hong Wang, Hong Tang, En-Qiang Chen
Viruses.2024; 16(4): 529. CrossRef Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 293. CrossRef Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 276. CrossRef Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening
Takako Inoue, Shintaro Yagi, Yasuhito Tanaka
Viruses.2024; 16(6): 848. CrossRef Novel biomarkers for chronic hepatitis B management
Tai-Chung Tseng
Clinical Liver Disease.2024;[Epub] CrossRef Role of circular RNAs in preeclampsia (Review)
Hengxue Jiang, Tao Meng, Ziwei Li
Experimental and Therapeutic Medicine.2024;[Epub] CrossRef Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus
Philippa C. Matthews, Ponsiano Ocama, Su Wang, Manal El-Sayed, Anna Turkova, Deborah Ford, Judith Torimiro, Ana Cristina Garcia Ferreira, Angélica Espinosa Miranda, Fernando Pio De La Hoz Restrepo, Emmanuel Seremba, Robinson Mbu, Calvin Q. Pan, Homie Raza
JHEP Reports.2023; 5(8): 100777. CrossRef
|